CAM
FPRX

ClariVest Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

ClariVest Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-26,714
Closed -$423K – 806
2018
Q2 		$423K Sell
26,714
-1,209
-4% -$21.1K 0.01% 519
2018
Q1 		$480K Buy
27,923
+100
+0.4% +$1.95K 0.01% 504
2017
Q4 		$610K Sell
27,823
-1,855
-6% -$59.7K 0.01% 469
2017
Q3 		$1.22M Hold
29,678
– – 0.03% 328
2017
Q2 		$894K Sell
29,678
-20
-0.1% -$624 0.02% 352
2017
Q1 		$1.07M Hold
29,698
– – 0.03% 332
2016
Q4 		$1.49M Sell
29,698
-11,930
-29% -$627K 0.04% 296
2016
Q3 		$2.18M Buy
41,628
+200
+0.5% +$9.55K 0.06% 200
2016
Q2 		$1.71M Buy
41,428
+30,228
+270% +$1.31M 0.05% 235
2016
Q1 		$455K Buy
11,200
+100
+0.9% +$3.44K 0.01% 362
2015
Q4 		$461K Sell
11,100
-3,900
-26% -$131K 0.01% 353
2015
Q3 		$231K Buy
15,000
+100
+0.7% +$2.15K 0.01% 406
2015
Q2 		$370K Buy
+14,900
New +$332K 0.01% 350

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ClariVest Asset Management's FPRX Position: Q3 2018 in Review

ClariVest Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2018, closing a stake of 26,714 shares — an estimated $423K sold.

ClariVest Asset Management first reported a position in FPRX in Q2 2015 and held it in 13 quarters. The position peaked at $2.18M in Q3 2016. 114 funds tracked by Wall St. Rank hold FPRX as of Q3 2018.

  • ClariVest Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • ClariVest Asset Management sold 26,714 Five Prime Therapeutics, Inc. shares in Q3 2018, an estimated $423K.
  • ClariVest Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 13 quarters.
  • ClariVest Asset Management's Five Prime Therapeutics, Inc. position peaked at $2.18M in Q3 2016.
  • 114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2018.

Based on ClariVest Asset Management's 13F filing for Q3 2018, filed 7 Nov 2018.